Marine Streptomyces sp. Isolated From the Brazilian Endemic Tunicate Euherdmania sp. Produces Dihydroeponemycin and Analogs With Potent Antiglioma Activity

Marine natural products have emerged as an important source for drug development, notably in the field of anticancer therapy. Still, the limited effectiveness of current therapies for central nervous system tumors indicates the need to identify new therapeutic targets and also novel pharmacological agents. In this context, proteasome inhibitors are appearing as a promising new treatment for these diseases. Herein, cytotoxic extracts produced by four marine bacteria recovered from the Brazilian endemic ascidian Euherdmania sp. were screened to evaluate their potential as proteasome inhibitors. The extract from marine Streptomyces sp. BRA-346 was selected for further investigation due to the potent proteasome inhibitory activity it displayed. Bioassay-guided fractionation led to an enriched fraction (proteasome inhibition IC50 = 45 ng/mL), in which the presence of dihydroeponemycin (DHE), known for its proteasome inhibitory effect, and related compounds were annotated by mass spectrometry and further confirmed by comparison with DHE standard. Both DHE and the epoxyketone-containing fraction were evaluated in glioma cell lines, displaying high cytotoxicity in HOG and T98G cells (GI50 of 1.6 and 1.7 ng/mL for DHE, and 17.6 and 28.2 ng/mL for the BRA-346 fraction, respectively). Additional studies showed that the epoxyketone-containing fraction (at GI50 levels) led to an accumulation of ubiquitinated proteins and up-regulation of genes related to ER-stress response, suggesting treated cells are under proteasome inhibition. DHE induced similar effects in treated cells but at concentrations 25 times its GI50, suggesting that the other epoxyketone compounds in the bacteria extract derived fraction may contribute to enhance proteasome inhibition and further cellular effects in glioma cells. These findings revealed the molecular pathways modulated by this class of compounds in glioma cells and, moreover, reinforced the potential of this marine bacteria in producing a cocktail of structurally-related compounds that affect the viability of glioma cells.

[1]  C. Touriol,et al.  ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both? , 2021, Biomolecules.

[2]  N. Krogan,et al.  Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A , 2021, Science.

[3]  A. Markham.  Lurbinectedin: First Approval , 2020, Drugs.

[4]  Hui Luo,et al.  Targeting the GRP78 Pathway for Cancer Therapy , 2020, Frontiers in Medicine.

[5]  I. Piña,et al.  Highlights of marine natural products having parallel scaffolds found from marine-derived bacteria, sponges, and tunicates , 2020, The Journal of Antibiotics.

[6]  M. Farzaei,et al.  Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases , 2020, Frontiers in Physiology.

[7]  A. Papavassiliou,et al.  Targeting of Endoplasmic Reticulum (ER) Stress in Gliomas. , 2020, Pharmacological research.

[8]  David J Newman,et al.  Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. , 2020, Journal of natural products.

[9]  Xu-li Tang,et al.  Biological and Chemical Diversity of Marine Sponge-Derived Microorganisms over the Last Two Decades from 1998 to 2017 , 2020, Molecules.

[10]  N. Lopes,et al.  Dextrorotatory Chromomycins from the Marine Streptomyces sp. Associated to Palythoa caribaeorum , 2020 .

[11]  Susana P. Gaudêncio,et al.  Enriching cancer pharmacology with drugs of marine origin , 2020, British journal of pharmacology.

[12]  F. Gago,et al.  Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells. , 2019, Biochemical pharmacology.

[13]  S. Lv,et al.  Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis , 2019, Cancer communications.

[14]  T. Lotufo,et al.  Marine Bacteria from Rocas Atoll as a Rich Source of Pharmacologically Active Compounds , 2019, Marine drugs.

[15]  Maruf M. U. Ali,et al.  UPR proteins IRE1 and PERK switch BiP from chaperone to ER stress sensor , 2019, Nature Structural & Molecular Biology.

[16]  A. Kornienko,et al.  Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets , 2019, Marine drugs.

[17]  David M. Smith,et al.  A Practical Review of Proteasome Pharmacology , 2019, Pharmacological Reviews.

[18]  Maruf M. U. Ali,et al.  Structure and Molecular Mechanism of ER Stress Signaling by the Unfolded Protein Response Signal Activator IRE1 , 2019, Front. Mol. Biosci..

[19]  S. Sidhu,et al.  Emerging drug development technologies targeting ubiquitination for cancer therapeutics , 2019, Pharmacology & Therapeutics.

[20]  H. Jang.  Regulation of Protein Degradation by Proteasomes in Cancer , 2018, Journal of cancer prevention.

[21]  David E. Williams,et al.  Bromopyrrole Alkaloid Inhibitors of the Proteasome Isolated from a Dictyonella sp. Marine Sponge Collected at the Amazon River Mouth. , 2018, Journal of natural products.

[22]  Changmin Kim,et al.  Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review , 2018, Nutrients.

[23]  J. E. Park,et al.  Next‐generation proteasome inhibitors for cancer therapy , 2018, Translational research : the journal of laboratory and clinical medicine.

[24]  Andreas Martin,et al.  Structure and Function of the 26S Proteasome. , 2018, Annual review of biochemistry.

[25]  M. Hallak,et al.  Arginylated Calreticulin Increases Apoptotic Response Induced by Bortezomib in Glioma Cells , 2018, Molecular Neurobiology.

[26]  T. Lotufo,et al.  Tunicates: A model organism to investigate the effects of associated-microbiota on the production of pharmaceuticals , 2018 .

[27]  Huan Wang,et al.  Enhanced Glioblastoma Targeting Ability of Carfilzomib Enabled by a DA7R-Modified Lipid Nanodisk. , 2018, Molecular pharmaceutics.

[28]  D. Watters.  Ascidian Toxins with Potential for Drug Development , 2018, Marine drugs.

[29]  Thomas C. Chen,et al.  Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model. , 2017, Journal of neurosurgery.

[30]  Ramón Cacabelos,et al.  Parkinson’s Disease: From Pathogenesis to Pharmacogenomics , 2017, International journal of molecular sciences.

[31]  R. Orlowski,et al.  Proteasome inhibitors in cancer therapy , 2017, Nature Reviews Clinical Oncology.

[32]  M. Mateos,et al.  Plitidepsin: design, development, and potential place in therapy , 2017, Drug design, development and therapy.

[33]  Satheesh Kumar Palanisamy,et al.  Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development , 2017, Natural Products and Bioprospecting.

[34]  A. Anel,et al.  Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo. , 2016, Cancer letters.

[35]  F. Kruyt,et al.  The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma. , 2016, Biochemical pharmacology.

[36]  F. Gago,et al.  Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin , 2016, Scientific Reports.

[37]  Kristian Fog Nielsen,et al.  Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking , 2016, Nature Biotechnology.

[38]  C. Muñoz-Pinedo,et al.  Cell death induced by endoplasmic reticulum stress , 2016, The FEBS journal.

[39]  J. Diehl,et al.  The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress. , 2016, Current molecular medicine.

[40]  M. Gertz,et al.  A practical review on carfilzomib in multiple myeloma , 2016, European journal of haematology.

[41]  A. Tay,et al.  Complementary Roles of GADD34- and CReP-Containing Eukaryotic Initiation Factor 2α Phosphatases during the Unfolded Protein Response , 2016, Molecular and Cellular Biology.

[42]  S. Stylli,et al.  Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib , 2016, Medical Oncology.

[43]  P. Snelgrove.  An Ocean of Discovery: Biodiversity Beyond the Census of Marine Life , 2016, Planta Medica.

[44]  Daniel P Demarque,et al.  Fragmentation reactions using electrospray ionization mass spectrometry: an important tool for the structural elucidation and characterization of synthetic and natural products. , 2016, Natural product reports.

[45]  Daming Zuo,et al.  Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications , 2016, Front. Immunol..

[46]  M. Trikha,et al.  Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier. , 2015, Neuro-oncology.

[47]  A. A. Stepanenko,et al.  Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability. , 2015, Gene.

[48]  D. Sherman,et al.  Identification and analysis of the bacterial endosymbiont specialized for production of the chemotherapeutic natural product ET-743. , 2015, Environmental microbiology.

[49]  Harun-Or Rashid,et al.  ER stress: Autophagy induction, inhibition and selection , 2015, Autophagy.

[50]  F. Mancini,et al.  Development and Application of a Novel SPE-Method for Bioassay-Guided Fractionation of Marine Extracts , 2015, Marine drugs.

[51]  F. Jerry Reen,et al.  Emerging Concepts Promising New Horizons for Marine Biodiscovery and Synthetic Biology , 2015, Marine drugs.

[52]  Jie Yuan,et al.  Statistical Research on the Bioactivity of New Marine Natural Products Discovered during the 28 Years from 1985 to 2012 , 2015, Marine drugs.

[53]  M. Kudo,et al.  Involvement of Heat Shock Protein A4/Apg-2 in Refractory Inflammatory Bowel Disease , 2014, Inflammatory bowel diseases.

[54]  I. Guarniero.  How Many Species Are There on Earth and in the Ocean? (PLOS Biology) , 2014 .

[55]  M. Zappalà,et al.  Peptide‐Based Proteasome Inhibitors in Anticancer Drug Design , 2014, Medicinal research reviews.

[56]  J. Venkatesan,et al.  Pharmaceutically active secondary metabolites of marine actinobacteria. , 2014, Microbiological research.

[57]  M. Schorn,et al.  Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors. , 2014, ACS chemical biology.

[58]  C. Hetz,et al.  When ER stress reaches a dead end. , 2013, Biochimica et biophysica acta.

[59]  H. Nishitoh,et al.  Signaling Pathways from the Endoplasmic Reticulum and Their Roles in Disease , 2013, Genes.

[60]  Maruf M. U. Ali,et al.  UPR Signal Activation by Luminal Sensor Domains , 2013, International journal of molecular sciences.

[61]  Amy S. Lee,et al.  The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies , 2013, Oncogene.

[62]  M. Michalak,et al.  Calreticulin signaling in health and disease. , 2012, The international journal of biochemistry & cell biology.

[63]  Huajun Zheng,et al.  Bacterial biosynthesis and maturation of the didemnin anti-cancer agents. , 2012, Journal of the American Chemical Society.

[64]  H. Overkleeft,et al.  Proteasome inhibitors: an expanding army attacking a unique target. , 2012, Chemistry & biology.

[65]  C. Hetz.  The unfolded protein response: controlling cell fate decisions under ER stress and beyond , 2012, Nature Reviews Molecular Cell Biology.

[66]  A. Tomoda,et al.  Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells , 2011, International journal of oncology.

[67]  B. Catalgol.  Proteasome and cancer. , 2012, Progress in molecular biology and translational science.

[68]  P. Walter,et al.  The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation , 2011, Science.

[69]  J. Fujimoto,et al.  Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B. , 2011, Journal of natural products.

[70]  Dong-Sun Han,et al.  C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-α and the critical period hypothesis of estrogen neuroprotection , 2011, Proceedings of the National Academy of Sciences.

[71]  C. Mora,et al.  How Many Species Are There on Earth and in the Ocean? , 2011, PLoS biology.

[72]  N. Myeku,et al.  Dynamics of the Degradation of Ubiquitinated Proteins by Proteasomes and Autophagy , 2011, The Journal of Biological Chemistry.

[73]  D. Ron,et al.  Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress , 2011, Nature Cell Biology.

[74]  A. Tomoda,et al.  Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress. , 2011, International journal of oncology.

[75]  P. Richardson,et al.  Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. , 2011, Current cancer drug targets.

[76]  Paul V. R. Snelgrove,et al.  Discoveries of the Census of Marine Life: Making Ocean Life Count , 2010 .

[77]  T. Kinzy,et al.  eEF1A: Thinking Outside the Ribosome* , 2010, The Journal of Biological Chemistry.

[78]  Risheng Ye,et al.  Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. , 2009, Antioxidants & redox signaling.

[79]  R. Kaufman,et al.  Regulation of apoptosis by the unfolded protein response. , 2009, Methods in molecular biology.

[80]  M. B. Davis,et al.  breast cancer cells , 2009 .

[81]  B. Levine,et al.  Dual Role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation , 2008, Autophagy.

[82]  Hui Li,et al.  Fragmentation study of a 8-C-glycosyl isoflavone, puerarin, using electrospray ion trap time-of-flight mass spectrometry at high resolution. , 2007, Rapid communications in mass spectrometry : RCM.

[83]  Hua-Qin Wang,et al.  Different induction of GRP78 and CHOP as a predictor of sensitivity to proteasome inhibitors in thyroid cancer cells. , 2007, Endocrinology.

[84]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[85]  M. Groll,et al.  20S proteasome and its inhibitors: crystallographic knowledge for drug development. , 2007, Chemical reviews.

[86]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[87]  L. Boise,et al.  Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. , 2006, Blood.

[88]  N. Lopes,et al.  Triple quadrupole tandem mass spectrometry of sesquiterpene lactones: a study of goyazensolide and its congeners. , 2005, Journal of mass spectrometry : JMS.

[89]  M. Mayer,et al.  Hsp70 chaperones: Cellular functions and molecular mechanism , 2005, Cellular and Molecular Life Sciences.

[90]  Cun-Yu Wang,et al.  Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma Cells , 2004, Molecular and Cellular Biology.

[91]  P. Richardson,et al.  Proteasome inhibition , 2004 .

[92]  D. Faulkner,et al.  Marine pharmacology , 2004, Antonie van Leeuwenhoek.

[93]  L. Hendershot,et al.  Delineation of a Negative Feedback Regulatory Loop That Controls Protein Translation during Endoplasmic Reticulum Stress* , 2003, Journal of Biological Chemistry.

[94]  T. Lotufo,et al.  Biological activity in extracts of ascidians (Tunicata, Ascidiacea) from the northeastern Brazilian coast , 2003 .

[95]  J. Ohnishi,et al.  ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. , 2003, Experimental cell research.

[96]  T. Mincer,et al.  Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora. , 2003, Angewandte Chemie.

[97]  K. Mori,et al.  Distinct roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the mammalian unfolded protein response. , 2002, The Biochemical journal.

[98]  M. Wiedmann,et al.  Interaction of the Eukaryotic Elongation Factor 1A with Newly Synthesized Polypeptides* , 2002, The Journal of Biological Chemistry.

[99]  J. Staunton,et al.  Fragmentation studies on monensin A by sequential electrospray mass spectrometry. , 2002, The Analyst.

[100]  M. Joullié,et al.  Natural products as probes of cell biology: 20 years of didemnin research , 2002, Medicinal research reviews.

[101]  佛坂 由可.  Interaction of the eukaryotic elongation factor 1A with newly synthesized polypeptides , 2002 .

[102]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[103]  C. Crews,et al.  The ubiquitin‐proteasome pathway and proteasome inhibitors , 2001, Medicinal research reviews.

[104]  R. Huber,et al.  A gated channel into the proteasome core particle , 2000, Nature Structural Biology.

[105]  Anne Bertolotti,et al.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response , 2000, Nature Cell Biology.

[106]  N. Shimizu,et al.  Expression of APG-2 protein, a member of the heat shock protein 110 family, in developing rat brain , 2000, Neurochemistry International.

[107]  C. Barbato,et al.  Proteasome Involvement and Accumulation of Ubiquitinated Proteins in Cerebellar Granule Neurons Undergoing Apoptosis , 2000, The Journal of Neuroscience.

[108]  C. Crews,et al.  Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency. , 1999, Bioorganic & medicinal chemistry letters.

[109]  C. Crews,et al.  Eponemycin exerts its antitumor effect through the inhibition of proteasome function. , 1999, Cancer research.

[110]  W. Baumeister,et al.  The 26S proteasome: a molecular machine designed for controlled proteolysis. , 1999, Annual review of biochemistry.

[111]  L. Pleyer,et al.  Regulation of apoptosis , 2007 .

[112]  H. Heuer,et al.  Analysis of actinomycete communities by specific amplification of genes encoding 16S rRNA and gel-electrophoretic separation in denaturing gradients , 1997, Applied and environmental microbiology.

[113]  A. Goldberg,et al.  Proteasome Inhibition Leads to a Heat-shock Response, Induction of Endoplasmic Reticulum Chaperones, and Thermotolerance* , 1997, The Journal of Biological Chemistry.

[114]  R. G. Hughes,et al.  Structure−Activity Relationships of the Didemnins1,2 , 1996 .

[115]  R. G. Hughes,et al.  Structure--activity relationships of the didemnins. , 1996, Journal of medicinal chemistry.

[116]  T. Oki,et al.  Epoxomicin, a new antitumor agent of microbial origin. , 1992, The Journal of antibiotics.

[117]  Stuart L. Schreiber,et al.  Natural Products as Probes of Cellular Function: Studies of Immunophilins , 1992 .

[118]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[119]  Paul A. Keifer,et al.  Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata , 1990 .

[120]  T. Oki,et al.  Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity. , 1990, The Journal of antibiotics.

[121]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[122]  R. G. Hughes,et al.  Didemnins: antiviral and antitumor depsipeptides from a caribbean tunicate. , 1981, Science.

[123]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[124]  K. Shadan,et al.  Available online: , 2012 .